Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 27, 2026
How Fred Hutch scientists tackle world’s top infectious killer, TB
Expertise in immunology and biostatistics underpin foundational work in tuberculosis vaccines, biomarkers and pathology that could usher in a new era
Dr. Elizabeth Halloran, expert in vaccine trial design and quantitative methods for infectious diseases, transitions to emerita
Infectious disease modeling pioneer helped outline modern precepts for design and analysis of vaccine trials, causal inference with interference; shaped a generation of infectious disease scientists
Dr. Peter Gilbert receives Marvin Zelen Leadership Award in Statistical Science
Award recognizes leadership in HIV vaccine trial development, analysis
Starting the year smarter
How patients, providers, researchers and others stay informed amid a deluge of data and information
Crunching the numbers for next-gen COVID-19 vaccines
BARDA taps Fred Hutch biostatisticians to assess new vaccine technology, more nimble trial design
New biomarker could one day help tailor immunotherapy for Merkel cell carcinoma
Helps explain why only certain MCC patients respond to immune checkpoint inhibitors, could point toward new strategies to improve treatment responses
Biostatistician Dr. Deborah Donnell named AAAS Fellow
Honor recognizes her key role in HIV prevention studies